With the increasing use of gonadotropin releasing hormone antagonist protocols, it has become an option to
trigger ovulation with gonadotropin releasing hormone agonist which has several advantages over human chorionic
gonadotropin triggering; among those an elimination or reduction in ovarian hyperstimulation syndrome, and a reduction
in luteal phase discomfort. Thus, this paper questions the automated use of human chorionic gonadotropin for triggering
of ovulation in assisted reproductive technologies.